Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress
Łukasz Bułdak
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid profileSearch for this author on
, Estera Skudrzyk
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid profileSearch for this author on
, Grzegorz Machnik
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid profileSearch for this author on
, Aleksandra Bołdys
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid profileSearch for this author on
, Rafał Jakub Bułdak
Institute of Medical Sciences, University of OpoleOpole, Poland
Orcid profileSearch for this author on
and Bogusław Okopień
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Orcid profileSearch for this author on
Feb 20, 2022
About this article